154 related articles for article (PubMed ID: 37033501)
1. Satisfaction With the Use of Subdermal Contraceptive Implant in Women Attending the Specialized Polyclinic Primary Health Care Center in Jeddah City: A Cross-Sectional Study.
Wali R; Alghamdi AM; Ahmed ST; Gammash AM; Bukhari MM; Alkhozam KF; Asiri MH
Cureus; 2023 Mar; 15(3):e35902. PubMed ID: 37033501
[TBL] [Abstract][Full Text] [Related]
2. Women's perceptions with use of Implanon
Mgobhozi LN; Mchunu GG; Mbeje P
Health SA; 2023; 28():2016. PubMed ID: 37927943
[TBL] [Abstract][Full Text] [Related]
3. User perspectives on Implanon NXT in South Africa: A survey of 12 public-sector facilities.
Pillay D; Chersich M; Morroni C; Pleaner M; Adeagbo OA; Naidoo N; Mullick S; Rees H
S Afr Med J; 2017 Oct; 107(10):815-821. PubMed ID: 29397680
[TBL] [Abstract][Full Text] [Related]
4. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Power J; French R; Cowan F
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
[TBL] [Abstract][Full Text] [Related]
5. Subdermal contraceptive implants.
Peralta O; Diaz S; Croxatto H
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
[TBL] [Abstract][Full Text] [Related]
6. [Acceptability of the etonogestrel-containing contraceptive implant (Implanon)].
Sergent F; Clamageran C; Bastard AM; Verspyck E; Marpeau L
J Gynecol Obstet Biol Reprod (Paris); 2004 Sep; 33(5):407-15. PubMed ID: 15480280
[TBL] [Abstract][Full Text] [Related]
7. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
[TBL] [Abstract][Full Text] [Related]
8. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
9. Reasons for requesting removal of the hormonal implant, Implanon NXT, at an urban reproductive health clinic in KwaZulu-Natal, South Africa.
Beesham I; Smit J; Beksinska M; Panday M; Makatini V; Evans S
S Afr Med J; 2019 Sep; 109(10):750-755. PubMed ID: 31635572
[TBL] [Abstract][Full Text] [Related]
10. Women's experiences on the use of Implanon as a contraceptive method in a selected primary healthcare facility in KwaZulu-Natal.
Mgobhozi LN; Mbeje PN; Mchunu GG
Curationis; 2021 Nov; 44(1):e1-e9. PubMed ID: 34797106
[TBL] [Abstract][Full Text] [Related]
11. Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
Beesham I; Smit J; Bosman SL; Milford C; Panday M; Beksinska M
Afr J Reprod Health; 2021 Feb; 25(1):41-48. PubMed ID: 34077109
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and factors associated with early discontinuation rate of Implanon utilization among women who ever used Implanon in Kucha District Gamo Gofa Zone, Southern Ethiopia.
Mamecha Mesha ; Akalewold Alemayehu ; Deresse Daka
BMC Womens Health; 2020 Oct; 20(1):239. PubMed ID: 33097056
[TBL] [Abstract][Full Text] [Related]
13. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
14. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
[TBL] [Abstract][Full Text] [Related]
15. Implanon: subdermal single rod contraceptive implant.
Bhatia P; Nangia S; Aggarwal S; Tewari C
J Obstet Gynaecol India; 2011 Aug; 61(4):422-5. PubMed ID: 22851825
[TBL] [Abstract][Full Text] [Related]
16. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
[TBL] [Abstract][Full Text] [Related]
17. Preliminary experience with Norplant in an inner city population.
Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
[TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
Aisien AO; Enosolease ME
Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
[TBL] [Abstract][Full Text] [Related]
19. Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users.
Asnake M; Henry EG; Tilahun Y; Oliveras E
Int J Gynaecol Obstet; 2013 Nov; 123 Suppl 1():e29-32. PubMed ID: 24035007
[TBL] [Abstract][Full Text] [Related]
20. "I think it depends on the body, with mine it didn't work": explaining young women's contraceptive implant removal.
Hoggart L; Newton VL; Dickson J
Contraception; 2013 Nov; 88(5):636-40. PubMed ID: 23829976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
